Name | azetidin-3-ol,hydrochloride |
---|---|
Synonyms |
3-Azetidinol Hydrochloride
azetidin-3-ol monohydrochloride MFCD02683887 Azetidin-3-ol hydrochloride 3-hydroxyazetidine monohydrochloride 3-Hydroxyazetidine-HCl azetidin-3-ol-hydrochloride 3-Azetidinol hydrochloride (1:1) 3-Azetidinol, hydrochloride (1:1) 3-hydroxy-1-azetidine hydrochloride azetidin-3-ol hcl 3-Hydroxyazetidine Hydrochloride 3-hydroxyazetidinium chloride 3 HYDROXY AZETIDINE HYDROCHLORIDE |
Description | Azetidin-3-ol hydrochloride is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azetidin-3-ol hydrochloride is also a alkyl chain-based PROTAC linker that can be used in the synthes PROTAC. |
---|---|
Related Catalog | |
Target |
Non-cleavable |
In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
References |
Boiling Point | 170.7ºC at 760 mmHg |
---|---|
Melting Point | 90-92°C |
Molecular Formula | C3H8ClNO |
Molecular Weight | 109.555 |
Flash Point | 120.4ºC |
Exact Mass | 109.029442 |
PSA | 32.26000 |
LogP | 0.08130 |
Vapour Pressure | 0.464mmHg at 25°C |
Storage condition | Room temperature. |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H315-H318-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | C,Xi,Xn |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36/37/39 |
RIDADR | NONH for all modes of transport |
HS Code | 2933990090 |
~99% 18621-18-6 |
Literature: Isoda, Takeshi; Ushirogochi, Hideki; Satoh, Koichi; Takasaki, Tsuyoshi; Yamamura, Itsuki; Sato, Chisato; Mihira, Ado; Abe, Takao; Tamai, Satoshi; Yamamoto, Shigeki; Kumagai, Toshio; Nagao, Yoshimitsu Journal of Antibiotics, 2006 , vol. 59, # 4 p. 241 - 247 |
~67% 18621-18-6 |
Literature: Adams, Jerry L.; Boehm, Jeffrey C.; Hall, Ralph; Jin, Qi; Kasparec, Jiri; Silva, Domingos J.; Taggart, John J. Patent: US2004/116697 A1, 2004 ; Location in patent: Page 82 ; US 20040116697 A1 |
~% 18621-18-6 |
Literature: WO2006/15194 A2, ; Page/Page column 14 ; |
~% 18621-18-6 |
Literature: WO2005/118572 A1, ; Page/Page column 198 ; WO 2005/118572 A1 |
~87% 18621-18-6 |
Literature: Krishna Reddy; Udaykiran; Chintamani; Mahesh Reddy; Kameswararao, Ch.; Madhusudhan Organic Process Research and Development, 2011 , vol. 15, # 2 p. 462 - 466 |
~99% 18621-18-6 |
Literature: Dave, Paritosh R. Journal of Organic Chemistry, 1996 , vol. 61, # 16 p. 5453 - 5455 |
~% 18621-18-6 |
Literature: Tetrahedron Letters, , vol. 40, # 19 p. 3761 - 3764 |
Precursor 8 | |
---|---|
DownStream 6 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |